The Experts below are selected from a list of 5130 Experts worldwide ranked by ideXlab platform
Ge Komaki - One of the best experts on this subject based on the ideXlab platform.
-
age and gender effect on alexithymia in large japanese community and clinical samples a cross validation study of the toronto alexithymia scale tas 20
Biopsychosocial Medicine, 2007Co-Authors: Yoshiya Moriguchi, Chiharu Kubo, Motonari Maeda, Tetsuya Igarashi, Toshio Ishikawa, Masayasu Shoji, Ge KomakiAbstract:Background The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for Psychosomatic Disorder patients has not been adequately investigated. Although alexithymia most likely has certain developmental aspects, this has infrequently been investigated.
Yoshiya Moriguchi - One of the best experts on this subject based on the ideXlab platform.
-
age and gender effect on alexithymia in large japanese community and clinical samples a cross validation study of the toronto alexithymia scale tas 20
Biopsychosocial Medicine, 2007Co-Authors: Yoshiya Moriguchi, Chiharu Kubo, Motonari Maeda, Tetsuya Igarashi, Toshio Ishikawa, Masayasu Shoji, Ge KomakiAbstract:Background The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for Psychosomatic Disorder patients has not been adequately investigated. Although alexithymia most likely has certain developmental aspects, this has infrequently been investigated.
Harvey Brooker - One of the best experts on this subject based on the ideXlab platform.
-
is alexithymia related to Psychosomatic Disorder and somatizing
Journal of Psychosomatic Research, 1994Co-Authors: Karen Cohen, Frank Auld, Harvey BrookerAbstract:Abstract The purpose of this study was to examine the relationship among alexithymia (as measured by the Toronto Alexithymia Scale—TAS and the scored version of the Archetypal 9 Test—SAT9), the presence or absence of classical Psychosomatic disease, and the experience and expression of physical signs and symptoms. Subjects included thirty-two physical signs and symptoms. Subjects included thirty- two in-patients on a Psychosomatic medicine unit (somatizing group), thirty-one out-patients who presented to a psychology clinic (psychiatric group), and thirty-four dental patients (comparison group). All subjects completed the TAS, the SAT9, the Hypochondriasis scale of the Minnesota Multiphasic Personality Inventory (MMPI Hs), the Physical Malfunctioning subscale of the MMPI (MMPI Physm), the Somatic Complaints subscale of the MMPI (MMPI Somc), the Hypochondriasis and Denial scales of the Basic Personality Inventory (BPI Hs and BPI Dn), and a demographic questionnaire. Age was significantly correlated with some of the TAS subscales (p
Akira Toyofuku - One of the best experts on this subject based on the ideXlab platform.
-
Psychosomatic problems in dentistry
Biopsychosocial Medicine, 2016Co-Authors: Akira ToyofukuAbstract:Many dental patients complain of oral symptoms after dental treatment, such as chronic pain or occlusal discomfort, for which the cause remains undetermined. These symptoms are often thought to be mental or emotional in origin, and patients are considered to have an “oral Psychosomatic Disorder”. Representative medically unexplained oral symptoms/syndromes (MUOS) include burning mouth syndrome, atypical odontalgia, phantom bite syndrome, oral cenesthopathy, or halitophobia. With an increasing prevalence of these MUOS, dentists are being asked to develop new approaches to dental treatment, which include taking care of not only the patient’s teeth but also the patient’s suffering. Progress in the understanding of mind-body interactions will lead to investigations on the pathophysiology of MUOS and the development of new therapeutic approaches.
-
Psychopharmacology and oral Psychosomatic Disorder
Nihon rinsho. Japanese journal of clinical medicine, 2012Co-Authors: Tatsuya Yoshikawa, Akira ToyofukuAbstract:It is uncommon to encounter patients presenting with medically and psychiatry unexplained oral symptoms like pain or discomfort. These symptoms have been called "oral Psychosomatic Disorders (OPSD)" in general. From a clinical point of view, OPSD may be due to several biochemical Disorders involving neurotransmitters in the brain, incomplete connections between oral region and undefined complaints due to cognitive processes in higher centers of the brain. The main Psychosomatic treatment is psychopharmacological therapy with antidepressants, including tricyclic antidepressants (TCAs), serotonin-norepinephrine reuptake inhibitors(SNRIs), selective serotonin reuptake inhibitors(SSRIs), and other antidepressants (e.g., mirtazapine)". The proper use of these antidepressants is extremely important for the successful treatment of OPSD.
Motonari Maeda - One of the best experts on this subject based on the ideXlab platform.
-
age and gender effect on alexithymia in large japanese community and clinical samples a cross validation study of the toronto alexithymia scale tas 20
Biopsychosocial Medicine, 2007Co-Authors: Yoshiya Moriguchi, Chiharu Kubo, Motonari Maeda, Tetsuya Igarashi, Toshio Ishikawa, Masayasu Shoji, Ge KomakiAbstract:Background The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for Psychosomatic Disorder patients has not been adequately investigated. Although alexithymia most likely has certain developmental aspects, this has infrequently been investigated.